|
US6608060B1
(en)
|
1996-12-18 |
2003-08-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
AU7966198A
(en)
|
1997-06-13 |
1998-12-30 |
Smithkline Beecham Corporation |
Novel pyrazole and pyrazoline substituted compounds
|
|
AU736746B2
(en)
*
|
1997-09-10 |
2001-08-02 |
Dainippon Ink And Chemicals Inc. |
2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals
|
|
US6858617B2
(en)
|
1998-05-26 |
2005-02-22 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
|
DE69914357T2
(de)
|
1998-11-04 |
2004-11-11 |
Smithkline Beecham Corp. |
Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
|
|
WO2000040243A1
(en)
|
1999-01-08 |
2000-07-13 |
Smithkline Beecham Corporation |
Novel compounds
|
|
EP1158985B1
(en)
|
1999-01-13 |
2011-12-28 |
Bayer HealthCare LLC |
OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
|
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
EP1169038B9
(en)
|
1999-04-15 |
2013-07-10 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
|
AU5316900A
(en)
*
|
1999-06-03 |
2000-12-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-jun n-terminal kinases (jnk)
|
|
EP1233950B1
(en)
|
1999-11-23 |
2005-10-05 |
Smithkline Beecham Corporation |
3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
|
|
JP2003514900A
(ja)
|
1999-11-23 |
2003-04-22 |
スミスクライン・ビーチャム・コーポレイション |
ＣＳＢＰ／ｐ３８キナーゼ阻害剤としての３，４−ジヒドロ−（１Ｈ）−キナゾリン−２−オン化合物
|
|
ATE281439T1
(de)
|
1999-11-23 |
2004-11-15 |
Smithkline Beecham Corp |
3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren
|
|
WO2001062731A1
(en)
*
|
2000-02-23 |
2001-08-30 |
Iconix Pharmaceuticals, Inc. |
Pyridine-amidines as modulators of p38 map kinase
|
|
US7235551B2
(en)
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
|
AU2001247700A1
(en)
*
|
2000-03-22 |
2001-10-03 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
JP4993838B2
(ja)
*
|
2000-08-11 |
2012-08-08 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｐ３８のインヒビターとしてのピリジン誘導体
|
|
US6645990B2
(en)
|
2000-08-15 |
2003-11-11 |
Amgen Inc. |
Thiazolyl urea compounds and methods of uses
|
|
WO2002092087A1
(en)
*
|
2001-05-11 |
2002-11-21 |
Vertex Pharmaceuticals Incorporated |
2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
|
|
ATE415162T1
(de)
*
|
2001-06-11 |
2008-12-15 |
Vertex Pharma |
Isochinolin-inhibitoren von p38
|
|
AU2002316421B2
(en)
*
|
2001-06-26 |
2008-05-15 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of TNF-ALPHA expression
|
|
SI1478358T1
(sl)
|
2002-02-11 |
2013-09-30 |
Bayer Healthcare Llc |
Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi
|
|
ATE375980T1
(de)
*
|
2002-02-12 |
2007-11-15 |
Smithkline Beecham Corp |
Nicotinamide und deren verwendung als p38 inhibitoren
|
|
GB0214268D0
(en)
*
|
2002-06-20 |
2002-07-31 |
Celltech R&D Ltd |
Chemical compounds
|
|
ES2278170T3
(es)
|
2002-07-09 |
2007-08-01 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG |
Composiciones farmaceuticas de anticolinergicos e inhibidores de la quinasa p38 en el tratamiento de enfermedades respiratorias.
|
|
RU2351590C2
(ru)
|
2003-02-10 |
2009-04-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ получения диариламина
|
|
EP1636585B2
(en)
|
2003-05-20 |
2012-06-13 |
Bayer HealthCare LLC |
Diaryl ureas with kinase inhibiting activity
|
|
EP1663978B1
(en)
|
2003-07-23 |
2007-11-28 |
Bayer Pharmaceuticals Corporation |
Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
|
|
CA2561718A1
(en)
|
2004-04-13 |
2005-10-27 |
Icagen, Inc. |
Polycyclic pyridines as potassium ion channel modulators
|
|
KR100575344B1
(ko)
*
|
2004-07-14 |
2006-05-03 |
주식회사 이큐스팜 |
Ｃ형 간염 예방 및 치료용 약학적 조성물
|
|
US20060035893A1
(en)
|
2004-08-07 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
|
WO2006021848A1
(en)
*
|
2004-08-27 |
2006-03-02 |
Ranbaxy Laboratories Limited |
Anti-inflammatory agents
|
|
US8017395B2
(en)
|
2004-12-17 |
2011-09-13 |
Lifescan, Inc. |
Seeding cells on porous supports
|
|
PE20060777A1
(es)
|
2004-12-24 |
2006-10-06 |
Boehringer Ingelheim Int |
Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
|
|
AU2006202209B2
(en)
|
2005-05-27 |
2011-04-14 |
Lifescan, Inc. |
Amniotic fluid derived cells
|
|
BRPI0502016B8
(pt)
*
|
2005-06-03 |
2021-05-25 |
Univ Federal Do Rio De Janeiro Ufrj |
composto ureídicos, composições farmacêuticas contendo os mesmos e seu uso no tratamento de doenças inflamatórias
|
|
JP2009500297A
(ja)
*
|
2005-06-08 |
2009-01-08 |
セントカー・インコーポレーテツド |
眼の変性についての細胞療法
|
|
US20070122448A1
(en)
*
|
2005-11-28 |
2007-05-31 |
Alireza Rezania |
Compositions and methods to create a vascularized environment for cellular transplantation
|
|
US8741643B2
(en)
*
|
2006-04-28 |
2014-06-03 |
Lifescan, Inc. |
Differentiation of pluripotent stem cells to definitive endoderm lineage
|
|
AU2007244675A1
(en)
|
2006-04-28 |
2007-11-08 |
Lifescan, Inc. |
Differentiation of human embryonic stem cells
|
|
CA2676044C
(en)
*
|
2007-01-30 |
2019-10-22 |
University Of Georgia Research Foundation, Inc. |
Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (mmc)
|
|
US20100104536A1
(en)
*
|
2007-03-20 |
2010-04-29 |
Indravadan Ambalal Modi |
P38 inhibitors
|
|
EP1992344A1
(en)
|
2007-05-18 |
2008-11-19 |
Institut Curie |
P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
|
|
US9080145B2
(en)
*
|
2007-07-01 |
2015-07-14 |
Lifescan Corporation |
Single pluripotent stem cell culture
|
|
EP3957716A1
(en)
|
2007-07-18 |
2022-02-23 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells
|
|
DK2185693T3
(da)
|
2007-07-31 |
2019-09-23 |
Lifescan Inc |
Differentiering af humane embryoniske stamceller
|
|
CA2954431C
(en)
|
2007-11-27 |
2021-08-24 |
Lifescan, Inc. |
Differentiation of human embryonic stem cells to pancreatic cells
|
|
JP5733986B2
(ja)
|
2008-02-21 |
2015-06-10 |
ヤンセン バイオテツク，インコーポレーテツド |
細胞の付着、培養、及び剥離のための方法、表面改質されたプレート、並びに組成物
|
|
US8623648B2
(en)
|
2008-04-24 |
2014-01-07 |
Janssen Biotech, Inc. |
Treatment of pluripotent cells
|
|
EP2942392B1
(en)
|
2008-06-30 |
2018-10-03 |
Janssen Biotech, Inc. |
Differentiation of pluripotent stem cells
|
|
US20110305672A1
(en)
|
2008-07-25 |
2011-12-15 |
University Of Georgia Research Foundation, Inc. |
COMPOSITIONS FOR MESODERM DERIVED ISL1+ MULTIPOTENT CELLS (IMPs), EPICARDIAL PROGENITOR CELLS (EPCs) AND MULTIPOTENT CD56C CELLS (C56Cs) AND METHODS OF PRODUCING AND USING SAME
|
|
AU2009274517B2
(en)
|
2008-07-25 |
2015-03-26 |
The University Of Georgia Research Foundation, Inc. |
Compositions for Mesoderm derived ISL1+ Multipotent cells (IMPs), epicardial progenitor cells (EPCs) and multipotent CXCR4+CD56+ cells (C56Cs) and methods of use
|
|
US20100028307A1
(en)
*
|
2008-07-31 |
2010-02-04 |
O'neil John J |
Pluripotent stem cell differentiation
|
|
WO2010038428A1
(ja)
*
|
2008-09-30 |
2010-04-08 |
武田薬品工業株式会社 |
タキサン系抗がん剤の置き換え薬
|
|
EP2350265B1
(en)
|
2008-10-31 |
2019-04-17 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
|
|
US9234178B2
(en)
|
2008-10-31 |
2016-01-12 |
Janssen Biotech, Inc. |
Differentiation of human pluripotent stem cells
|
|
KR101774546B1
(ko)
|
2008-11-20 |
2017-09-04 |
얀센 바이오테크 인코포레이티드 |
마이크로-캐리어 상의 만능 줄기 세포 배양
|
|
KR101687344B1
(ko)
*
|
2008-11-20 |
2016-12-16 |
얀센 바이오테크 인코포레이티드 |
평면 기재상의 세포 부착 및 배양을 위한 방법 및 조성물
|
|
CN102356066A
(zh)
*
|
2008-12-10 |
2012-02-15 |
同和药品株式会社 |
新型2，6-取代的-3-硝基吡啶衍生物、其制备方法及包含有其的药物组合物
|
|
WO2010077955A1
(en)
|
2008-12-17 |
2010-07-08 |
The Scripps Research Institute |
Generation and maintenance of stem cells
|
|
EP2396302A2
(en)
*
|
2009-02-13 |
2011-12-21 |
Vertex Pharmceuticals Incorporated |
Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides)
|
|
GB0908317D0
(en)
*
|
2009-05-14 |
2009-06-24 |
Argenta Discovery Ltd |
Pharmaceutical compounds and compositions
|
|
CN103952372B
(zh)
*
|
2009-07-20 |
2016-10-05 |
詹森生物科技公司 |
人胚胎干细胞的分化
|
|
CN102482643B
(zh)
|
2009-07-20 |
2016-06-29 |
詹森生物科技公司 |
人胚胎干细胞的分化
|
|
US8785184B2
(en)
|
2009-07-20 |
2014-07-22 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells
|
|
PL2494035T3
(pl)
|
2009-10-29 |
2018-07-31 |
Janssen Biotech, Inc. |
Pluripotencjalne komórki macierzyste
|
|
CN102712902B
(zh)
*
|
2009-12-23 |
2019-01-08 |
詹森生物科技公司 |
人胚胎干细胞的分化
|
|
SG10201408552YA
(en)
|
2009-12-23 |
2015-02-27 |
Janssen Biotech Inc |
Differentiation of human embryonic stem cells
|
|
PH12012501686A1
(en)
|
2010-03-01 |
2020-10-19 |
Janssen Biotech Inc |
Methods for purifying cells derived from pluripotent stem cells
|
|
RU2587634C2
(ru)
|
2010-05-12 |
2016-06-20 |
Янссен Байотек, Инк. |
Дифференцирование эмбриональных стволовых клеток человека
|
|
KR20190027969A
(ko)
|
2010-08-12 |
2019-03-15 |
얀센 바이오테크 인코포레이티드 |
췌장 내분비 전구 세포를 이용한 당뇨병의 치료
|
|
EP3372672A1
(en)
|
2010-08-31 |
2018-09-12 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells
|
|
CN103154237B
(zh)
|
2010-08-31 |
2016-03-16 |
詹森生物科技公司 |
多能干细胞的分化
|
|
PL2853589T3
(pl)
|
2010-08-31 |
2018-05-30 |
Janssen Biotech, Inc |
Różnicowanie ludzkich zarodkowych komórek macierzystych
|
|
JP6139410B2
(ja)
|
2010-12-02 |
2017-05-31 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
角膜細胞の作製方法および該角膜細胞を含む細胞集団
|
|
EP2652125B1
(en)
|
2010-12-15 |
2017-04-26 |
Kadimastem Ltd. |
Insulin producing cells derived from pluripotent stem cells
|
|
FI2794857T3
(fi)
|
2011-12-22 |
2026-03-25 |
Janssen Biotech Inc |
Ihmisen alkion kantasolujen erilaistaminen yksittäisiksi hormonaalisiksi insuliinipositiivisiksi soluiksi
|
|
CA2866590A1
(en)
|
2012-03-07 |
2013-09-12 |
Janssen Biotech, Inc. |
Defined media for expansion and maintenance of pluripotent stem cells
|
|
WO2013162027A1
(ja)
|
2012-04-27 |
2013-10-31 |
学校法人 慶應義塾 |
神経分化促進剤
|
|
EP3450544A1
(en)
|
2012-06-08 |
2019-03-06 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells into pancreatic endodrine cells
|
|
BR112015015714A2
(pt)
|
2012-12-31 |
2017-07-11 |
Janssen Biotech Inc |
suspensão e aglomeração de células pluripotentes humanas para diferenciação em célu-las endócrinas pancreáticas
|
|
ES2837763T3
(es)
|
2012-12-31 |
2021-07-01 |
Janssen Biotech Inc |
Cultivo de células madre embrionarias humanas en la interconexión aire-líquido para la diferenciación en células endocrinas pancreáticas
|
|
DK2938723T3
(da)
|
2012-12-31 |
2023-02-20 |
Janssen Biotech Inc |
Differentiering af humane embryonale stamceller til pancreatiske endokrine celler under anvendelse af hb9-regulatorer
|
|
US10370644B2
(en)
|
2012-12-31 |
2019-08-06 |
Janssen Biotech, Inc. |
Method for making human pluripotent suspension cultures and cells derived therefrom
|
|
US12558316B2
(en)
|
2013-03-13 |
2026-02-24 |
University Of Miami |
Methods and compositions for the treatment of epidermolysis bullosa
|
|
WO2014159662A1
(en)
|
2013-03-13 |
2014-10-02 |
University Of Miami |
Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
|
|
WO2015175307A1
(en)
|
2014-05-16 |
2015-11-19 |
Janssen Biotech, Inc. |
Use of small molecules to enhance mafa expression in pancreatic endocrine cells
|
|
EP3368052B1
(en)
|
2015-10-27 |
2021-12-08 |
Children's Hospital Medical Center |
Use of mapk inhibitors to reduce loss of hematopoietic stem cells during ex vivo culture and genetic manipulation
|
|
HK1254740A1
(zh)
|
2015-11-30 |
2019-07-26 |
Kadimastem Ltd. |
分化和纯化胰腺内分泌细胞的方法
|
|
US10420803B2
(en)
|
2016-04-14 |
2019-09-24 |
Janssen Biotech, Inc. |
Differentiation of pluripotent stem cells to intestinal midgut endoderm cells
|
|
US10342786B2
(en)
|
2017-10-05 |
2019-07-09 |
Fulcrum Therapeutics, Inc. |
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
|
|
BR112020006677A2
(pt)
|
2017-10-05 |
2020-10-06 |
Fulcrum Therapeutics, Inc. |
uso de inibidores p38 para reduzir a expressão de dux4
|
|
KR20200121800A
(ko)
*
|
2018-01-05 |
2020-10-26 |
싸이브렉사 1, 인크. |
산성 또는 저산소성 질환에 걸린 조직에 관련된 질환의 치료를 위한 화합물, 조성물 및 방법
|
|
EP3773579A4
(en)
|
2018-03-26 |
2022-03-09 |
Clear Creek Bio, Inc. |
COMPOSITIONS AND METHODS FOR INHIBITING DIHYDROOROTATE DEHYDROGENASE
|
|
US11555019B2
(en)
|
2019-07-10 |
2023-01-17 |
Cybrexa 3, Inc. |
Peptide conjugates of microtubule-targeting agents as therapeutics
|
|
MX2022000449A
(es)
|
2019-07-10 |
2022-04-25 |
Cybrexa 2 Inc |
Conjugados peptídicos de citotoxinas como terapéuticos.
|
|
WO2021189018A1
(en)
|
2020-03-20 |
2021-09-23 |
Clear Creek Bio, Inc. |
Methods of treating viral infections using inhibitors of nucleotide synthesis pathways
|
|
AU2021327376A1
(en)
|
2020-08-21 |
2023-04-20 |
University Of Miami |
Compositions and methods of treatment using microvesicles from bone marrow-derived mesenchymal stem cells
|
|
EP4511045A1
(en)
|
2022-04-19 |
2025-02-26 |
University of Miami |
Compositions comprising microvesicles for use in the prevention and treatment of graft versus host disease
|